Oral acyclovir therapy of recurrent herpes simplex virus type 2 infection of the hand.
Acyclovir was evaluated as treatment of recurrent herpes simplex virus type 2 infection of the hand in a double-blind, placebo-controlled crossover study. In nine fully evaluable patients, oral acyclovir (2 g/day in three doses for 10 days) initiated during the earliest phase of a recurrence reduced...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1991
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245012/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1850971/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.2.382 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|